TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14
P3 Health Partners Inc. Class A
P3 Health Partners Inc. Class A PIII | 0.00 |
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:
PIII) with a Hold and raises the price target from $3 to $14.
